Loading asset research
Atossa Therapeutics Inc. Common Stock
ATOSNasdaq · USD · StocksQuote as of · Exchange session not verified$2.51
+7.26%
Today
ATOS
Loading 1D prices…
Market cap
$25M
Volume
58.6K
52w high
$19.3552w low
$1.70Company profile
Atossa Therapeutics Inc. Common Stock
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Seattle, WA, United States
Employees
16
Fiscal year end
1231
CIK
1488039
Session & valuation
Open$2.36
Previous close$2.34
Day high$2.54
Day low$2.36
30-day avg. volume56.7K
Outstanding shares10M
Diluted EPS-$4.04
Latest annual period
P/E (trailing)-0.62
P/E (forward)-0.57
Price / book0.93
Beta1.27
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| TXMDTherapeuticsMD Inc. Common Stock | $25M | $3M | -18.83% | -$0.05 | +2.86% | Unrated |
| TVRDTvardi Therapeutics Inc. Common Stock | $24.9M | $0.00 | — | -$3.26 | +1.91% | Buy |
| OPTHOptimi Health Corp. Common Shares | $25.3M | — | — | -$1.20 | -0.89% | Hold |
| ACTUActuate Therapeutics Inc. Common stock | $25.7M | $0.00 | — | -$1.06 | -6.96% | Buy |
| NNVCNanoViricides Inc. Common Stock | $26M | $0.00 | — | -$0.31 | -0.98% | Buy |